Zoetis Belgium
Records under this name other than patents Zoetis Belgium holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Zoetis Belgium
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,354,522 | Immunostimulatory oligoribonucleotides Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,153,141 | Immunostimulatory G, U-containing oligoribonucleotides Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,662,949 | Immunostimulatory oligoribonucleotides Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,227,447 | RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,466,124 | RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,128,944 | RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,456,463 | Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,658,607 | Immunostimulatory G, U-containing oligoribonucleotides Formerly held Term ended Term ended May 28, 2024 · USPTO record | Term ended | Term ended May 28, 2024 | USPTO record |